Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease
Clinical trial NCT00481520 · COMPLETED
Trial details
- NCT number
- NCT00481520
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2008-01-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.